| Authors | J Madelaine, J Cadranel, G Zalcman |
| Journal | Revue des maladies respiratoires
(Rev Mal Respir)
Vol. 21
Issue 5 Pt 1
Pg. 881-5
(Nov 2004)
ISSN: 0761-8425 [Print] France |
| Vernacular Title | Prédiction de la réponse au Gefitinib (IRESSA) dans les adénocarcinomes bronchopulmonaires: les bases rationnelles du ciblage thérapeutique. |
| PMID | 15622331
(Publication Type: Editorial, Review)
|
| Chemical References |
- Antineoplastic Agents
- Quinazolines
- Epidermal Growth Factor
- ErbB Receptors
- Protein-Tyrosine Kinases
- Proto-Oncogene Proteins c-raf
- Gefitinib
|
| Topics |
- Adenocarcinoma
(drug therapy, genetics)
- Antineoplastic Agents
(pharmacology, therapeutic use)
- Epidermal Growth Factor
(antagonists & inhibitors)
- ErbB Receptors
(antagonists & inhibitors, genetics)
- Gefitinib
- Genes, erbB-1
- Humans
- Lung Neoplasms
(drug therapy, genetics)
- Mutation
- Protein-Tyrosine Kinases
(antagonists & inhibitors)
- Proto-Oncogene Proteins c-raf
(genetics)
- Quinazolines
(pharmacology, therapeutic use)
|
